linvoseltamab
Active substance: linvoseltamab
SOLUTION · LINVOSELTAMAB 120 g/L
United StatesActive
Marketing holder: Regeneron Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- LINVOSELTAMAB · 120 g/L
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208f-8243-76b9-adc9-0bcef85f0161;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 61755-954
- Registration status
- Active
- Dispensing
- Prescription only
Sources
- product · openFDA NDC · 61755-954 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 61755-954 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 61755-954 · Verified 2026-10-09 · open in source